Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Oxytocin in Moderate to Heavy Social Alcohol Drinkers
NCT01829516Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- May 2013
- Primary completion
- May 2014
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of oxytocin nasal spray in alcohol use disorder (AUD) (2 arms), sponsored by University of California, San Francisco. Primary endpoint: Change in Craving on the Alcohol Urge Questionnaire. Started May 2013; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT01829516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01829516.